找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antiviral Drug Discovery and Development; Xinyong Liu,Peng Zhan,Vasanthanathan Poongavanam Book 2021 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: 游牧
31#
發(fā)表于 2025-3-26 21:23:55 | 只看該作者
32#
發(fā)表于 2025-3-27 01:47:34 | 只看該作者
33#
發(fā)表于 2025-3-27 05:18:57 | 只看該作者
https://doi.org/10.1007/978-3-030-80538-8has increased the cure rates to nearly 100%. DAA therapy is among the best examples of success in the fight against viral infections. DAAs have transformed HCV management and have opened the door for the global eradication of HCV.
34#
發(fā)表于 2025-3-27 11:43:26 | 只看該作者
35#
發(fā)表于 2025-3-27 13:43:23 | 只看該作者
36#
發(fā)表于 2025-3-27 17:46:24 | 只看該作者
Moving Fast Toward Hepatitis B Virus Elimination,-HBV drug development strategies. Many of them are already in clinical trial phase 1 or 2, while others with promising results are still in preclinical stages. As research intensifies, potential HBV curative therapies and modalities in the pipeline are now on the horizon.
37#
發(fā)表于 2025-3-27 23:06:39 | 只看該作者
Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection,has increased the cure rates to nearly 100%. DAA therapy is among the best examples of success in the fight against viral infections. DAAs have transformed HCV management and have opened the door for the global eradication of HCV.
38#
發(fā)表于 2025-3-28 03:22:30 | 只看該作者
Exploiting Ubiquitin Ligases for Induced Target Degradation as an Antiviral Strategy,the UPS to degrade antiviral cellular host factors. Finally, I describe how we can exploit the same proteolytic machinery to enable PROTACs (Proteolysis-Targeting Chimeras) to degrade essential viral proteins. Successful implementation of this modality will add to the arsenal of emerging antiviral t
39#
發(fā)表于 2025-3-28 07:57:27 | 只看該作者
40#
發(fā)表于 2025-3-28 12:49:01 | 只看該作者
An Update on Antiretroviral Therapy,uture prospects towards reducing pill burden and developing long-acting drugs and novel antiretroviral therapies. In addition, we summarize efforts to cure HIV, including pharmaceutical strategies focused on the elimination of the virus.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 09:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南城县| 登封市| 涞水县| 罗江县| 漳平市| 义乌市| 长治市| 泸溪县| 繁昌县| 昆山市| 壶关县| 塔城市| 延川县| 志丹县| 井冈山市| 宁城县| 黔东| 兴安县| 辽阳县| 宁强县| 商丘市| 平利县| 仁化县| 阜康市| 商水县| 荣昌县| 乌兰察布市| 九龙城区| 雅安市| 榆中县| 五峰| 泰来县| 宝兴县| 资源县| 公安县| 墨玉县| 荥经县| 平顶山市| 隆回县| 丁青县| 囊谦县|